Razpipadon (developmental code names CVL-871, PF-06669571, PW-0464) is a dopamine receptor agonist which is under development for the treatment of dementia-related...
4 KB (214 words) - 00:46, 4 August 2024
phase 3 clinical trials for Parkinson's disease. Mevidalen (LY-3154207) Razpipadon (CVL-871) Bezard E, Gray D, Kozak R, Leoni M, Combs C, Duvvuri S (2024)...
6 KB (410 words) - 02:00, 6 August 2024
attention deficit hyperactivity disorder (ADHD). Glovadalen (UCB-0022) Razpipadon (CVL-871) Tavapadon (CVL-751) "Mevidalen - Eli Lilly and Company". AdisInsight...
7 KB (552 words) - 08:29, 14 August 2024